Showing results (31-40 of 789) with videos related to
Sort By:
Pageof 79
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
New Targets and New Agents in High-Risk Multiple MyelomaAjay K Nooka, Sagar LonialFuture Oncology (London, England)|November 29, 2007
PI3 kinase/AKT pathway as a therapeutic target in multiple myelomaR Donald Harvey, Sagar LonialClinical Lymphoma, Myeloma & Leukemia|November 1, 2011
High-risk multiple myeloma: does it still exist?Sascha A Tuchman, Sagar LonialClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Integration of Novel Agents into the Care of Patients with Multiple MyelomaRobert Z Orlowski, Sagar LonialMed (New York, N.Y.)|September 14, 2024
How to rescue a DreaMM deferred …Nisha S Joseph, Sagar LonialSeminars in Oncology|October 19, 2013
The future of drug development and therapy in myelomaSagar Lonial, Lawrence H BoiseOncology (Williston Park, N.Y.)|September 5, 2014
Current advances in novel proteasome inhibitor-based approaches to the treatment of relapsed/refractory multiple myelomaSagar Lonial, Lawrence H BoiseCA: a Cancer Journal for Clinicians|January 10, 2023
Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practiceRujul H Parikh, Sagar LonialBiologics : Targets & Therapy|February 13, 2016
Emerging treatments in Castleman disease - a critical appraisal of siltuximabJean L Koff, Sagar LonialClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar LonialPageof 79